Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24445720 | 0.83 | HPGD (0.45) | HPGDNPC1RAB9AALDH1A1CA12 | |
| SCHEMBL24445719 | 0.82 | MAPK1 (0.50) | HPGDNPC1RAB9AALDH1A1CA12 | |
| SCHEMBL7652240 | 0.81 | HPGD (0.50) | HPGDNPC1RAB9ANR1H4ALDH1A1 | |
| SCHEMBL9701622 | 0.80 | UNG (0.44) | ALDH1A1LMNAHSD17B10PLK1STS | |
| SCHEMBL19987340 | 0.78 | ALDH1A1 (0.48) | HPGDNPC1RAB9AALDH1A1MAPT | |
| SCHEMBL19985758 | 0.75 | HPGD (0.46) | HPGDNPC1RAB9ANR1H4ALDH1A1 | |
| SCHEMBL547838 | 0.74 | KCNH2 (0.60) | HPGDNPC1RAB9AALDH1A1CA1 | |
| SCHEMBL9711161 | 0.73 | ESR1 (0.63) | ALDH1A1CA1CA2MEN1LMNA | |
| SCHEMBL19985670 | 0.72 | ALDH1A1 (0.48) | HPGDALDH1A1MAPTMEN1GAA | |
| SCHEMBL48879 | 0.72 | HPGD (0.58) | HPGDNPC1RAB9AALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3516019-B1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS CORP (US) | 2023-06-14 | — | — | EP | disclosed |
| EP-3516020-B1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS CORP (US) | 2022-05-25 | — | — | EP | disclosed |
| US-10723969-B2 | Lubricant compositions stabilized by mixtures of diarylamine and hydroxydiarylamine antioxidants | LANXESS SOLUTIONS US INC. (US) | 2020-07-28 | — | — | US | disclosed |
| US-10563145-B2 | Alkylated 3-hydroxydiphenylamine antioxidants | LANXESS SOLUTIONS US INC. (US) | 2020-02-18 | — | — | US | disclosed |
| WO-2018057364-A1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. (US) | 2018-03-29 | — | — | WO | disclosed |
| WO-2018057366-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. (US) | 2018-03-29 | — | — | WO | disclosed |
| US-20180079987-A1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
| US-20180079985-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
| US-20180079987-A1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
| US-20180079985-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079985-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | GPX4, GSTO1, LPO | HPGD 97/4885NPC1 661/4885RAB9A 4561/4885 |
| US-10563145-B2 | Alkylated 3-hydroxydiphenylamine antioxidants | GPX4, GSTO1, LPO | HPGD 97/4885NPC1 661/4885RAB9A 4561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.